Organogenesis Holdings (ORGO) Long-Term Investments (2016 - 2018)

Organogenesis Holdings' Long-Term Investments history runs 3 years deep, the most recent figure standing at $316.3 million for Q3 2018.

• In Q3 2018, Long-Term Investments rose 1.48% year-over-year to $316.3 million; the TTM figure through Sep 2018 stood at $316.3 million (up 1.48% YoY), while the FY2017 annual figure was $312.5 million, up 0.81% from the prior year.
• Long-Term Investments was $316.3 million for Q3 2018 at Organogenesis Holdings, roughly flat from $314.8 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $316.3 million in Q3 2018 to a low of $310.0 million in Q4 2016.
• Historically, Long-Term Investments has averaged $312.4 million across 3 years, with a median of $312.1 million in 2017.
• The sharpest annual moves came in 2017 and 2018: Long-Term Investments gained 0.81% in 2017, then grew 1.48% in 2018.
• A 3-year view of Long-Term Investments shows it stood at $310.0 million in 2016, then advanced by 0.81% to $312.5 million in 2017, then climbed by 1.21% to $316.3 million in 2018.
• The last three Long-Term Investments figures came in at $316.3 million (Q3 2018), $314.8 million (Q2 2018), and $313.2 million (Q1 2018), per Business Quant data.